1. Home /
  2. Life Sciences

Life Sciences

Cambrex Soars on Buyout Deal With Private-Equity Firm Permira

Cambrex Soars on Buyout Deal With Private-Equity Firm Permira

Shares of life-sciences company Cambrex surge after the company strikes a deal to be acquired by pharmaceutical-focused private-equity firm Permira funds for $2.4 billion, including debt.

3 Iconic American Companies, Only 2 of Which Are Celebrating This July 4th

3 Iconic American Companies, Only 2 of Which Are Celebrating This July 4th

Shares of Hershey and Corning have done well since the last Fourth of July, but not so the stock of Harley-Davidson.

How to Profit as Plant-Based Meat Takes Off

How to Profit as Plant-Based Meat Takes Off

Look further down the literal food chain than Beyond Meat and Impossible Burger. And also, here's one stock to potentially avoid.

Thermo Fisher Scientific Is Showing Us 3 Strong Charts

Thermo Fisher Scientific Is Showing Us 3 Strong Charts

Here's how to play the stock right now.

What Is CBD Isolate?

What Is CBD Isolate?

CBD Isolate is the purest form of CBD - here's what it is, how it's made, and how to ingest it.

This Blue Origin Space Capsule Will Be Carrying Humans Soon

This Blue Origin Space Capsule Will Be Carrying Humans Soon

Blue Origin says its New Shepard space capsule will be carrying humans soon.

What Is Full-Spectrum CBD?

What Is Full-Spectrum CBD?

Full-spectrum CBD takes a team approach to tackling various physical and emotional health issues. Does it work?

Allergan Stock Slips Despite Beat and Raised Guidance

Allergan Stock Slips Despite Beat and Raised Guidance

Shares of the maker of Botox are struggling despite its latest results exceeding expectations.

CBD Oil vs. Hemp Oil: What's the Difference in 2019?

CBD Oil vs. Hemp Oil: What's the Difference in 2019?

CBD oil and hemp oil have different scientific elements, but both claim to fight common ailments that are giving the oils a growing fan base.

Why CBD's Invasion Into Pantries and Medicine Cabinets Is Inevitable

Why CBD's Invasion Into Pantries and Medicine Cabinets Is Inevitable

Cannabis' non-psychoactive derivative could disrupt the CPG (Consumer Product Group) space very soon. Watch the video for the more on the opportunities and challenges.